A Study for Treatment of Partial Seizures in Children

Status Completed

Clinical Trial Summary

The purpose of the study is to assess the safety profile of the investigational medication, Depakote Sprinkle Capsules, in the treatment of partial seizures in children ages 3-10.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00102713
Study type	Interventional
Source	Abbott
Contact
Status	Completed
Phase	Phase 3
Start date	February 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01954121` - Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures	Phase 3
Completed	`NCT01630057` - Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug	Phase 4
Completed	`NCT00327717` - Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures	Phase 3
Completed	`NCT00537238` - Pregabalin Versus Levetiracetam In Partial Seizures	Phase 3
Completed	`NCT00141258` - Pregabalin Epilepsy Add-On Trial	Phase 3
Completed	`NCT03340064` - A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age	Phase 3
Terminated	`NCT00407797` - Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial	Phase 4
Completed	`NCT01136954` - A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study)	Phase 3
Completed	`NCT04257604` - A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures
Completed	`NCT01392768` - Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization	Phase 3
Completed	`NCT01063764` - An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures	Phase 3
Completed	`NCT01262677` - Once-A-Day Pregabalin For Partial Seizures	Phase 3